Amphastar Pharmaceuticals, Inc. — Director's Dealing 2017

Jul 7, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2017-07-05

Reporting Person: Shandell Jason B. (Director, President and General Counsel)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-05	Common Stock	F	3394	$17.95	Disposed	235493	Direct

Footnotes

F1: The reported shares were withheld to satisfy the reporting person's tax liability in connection with the vesting of RSUs.

F2: Includes 1,199 shares acquired under the Issuer's 2014 Employee Stock Purchase Plan on May 31, 2017.